The University of Arkansas’ Technology Ventures program is highlighting inventor Susanne Striegler in their latest Inventor Spotlight series. Striegler, an associate professor in the Department of Biological Sciences, is being recognized for her innovative research and inventions in the field of biotechnology.
Striegler’s research focuses on developing novel approaches for the treatment of diseases such as cancer and diabetes using natural products and compounds. Her work has led to the development of several patented technologies that have the potential to revolutionize the way these diseases are treated.
One of Striegler’s most notable inventions is a new drug delivery system that utilizes nanoparticles to target specific cells in the body. This technology has the potential to improve the efficacy and reduce the side effects of traditional treatments for a variety of diseases.
In addition to her research, Striegler is also passionate about mentoring the next generation of scientists and entrepreneurs. She has worked with students and fellow researchers to help them develop their own innovative ideas and inventions.
The Technology Ventures program at the University of Arkansas plays a key role in supporting inventors like Striegler by providing funding, resources, and guidance to help bring their inventions to market. Through programs like the Inventor Spotlight series, the university aims to showcase the groundbreaking work being done by its faculty and inspire others to pursue their own entrepreneurial endeavors.
Overall, Susanne Striegler’s work exemplifies the innovative spirit and commitment to excellence that defines the University of Arkansas’ research community. Her inventions have the potential to have a significant impact on the field of biotechnology and beyond, making her a valuable asset to both the university and the wider scientific community.
Source
Photo credit news.google.com
